−3.5TWD
−1.16 BTWD
389.62 MTWD
238.81 M
About MEDIGEN VACCINE BIOLOGICS CORPORATE
Sector
Industry
CEO
Tsan Jian Chen
Website
Headquarters
Zhubei
Founded
2012
ISIN
TW0006547003
FIGI
BBG009PX9G96
Medigen Vaccine Biologics Corp. engages in the research, development, and wholesale of vaccine and biopharmaceutical, and wholesale and retail of medical devices. The company was founded on October 12, 2012 and is headquartered in Zhubei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6547 is 52.0 TWD — it has decreased by 0.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEDIGEN VACCINE BIOLOGICS CORPORATE stocks are traded under the ticker 6547.
MEDIGEN VACCINE BIOLOGICS CORPORATE is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6547 stock is 2.91% volatile and has beta coefficient of −0.09. Check out the list of the most volatile stocks — is MEDIGEN VACCINE BIOLOGICS CORPORATE there?
6547 earnings for the last quarter are −0.65 TWD per share, whereas the estimation was −1.06 TWD resulting in a 38.68% surprise. The estimated earnings for the next quarter are −0.54 TWD per share. See more details about MEDIGEN VACCINE BIOLOGICS CORPORATE earnings.
MEDIGEN VACCINE BIOLOGICS CORPORATE revenue for the last quarter amounts to 24.00 M TWD despite the estimated figure of 2.50 B TWD. In the next quarter revenue is expected to reach 3.00 M TWD.
Yes, you can track MEDIGEN VACCINE BIOLOGICS CORPORATE financials in yearly and quarterly reports right on TradingView.
6547 stock has risen by 1.96% compared to the previous week, the month change is a 2.99% fall, over the last year MEDIGEN VACCINE BIOLOGICS CORPORATE has showed a 23.75% decrease.
6547 net income for the last quarter is −582.14 M TWD, while the quarter before that showed −52.03 M TWD of net income which accounts for −1.02 K% change. Track more MEDIGEN VACCINE BIOLOGICS CORPORATE financial stats to get the full picture.
Today MEDIGEN VACCINE BIOLOGICS CORPORATE has the market capitalization of 16.53 B, it has increased by 1.34% over the last week.
No, 6547 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGEN VACCINE BIOLOGICS CORPORATE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIGEN VACCINE BIOLOGICS CORPORATE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIGEN VACCINE BIOLOGICS CORPORATE stock shows the sell signal. See more of MEDIGEN VACCINE BIOLOGICS CORPORATE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGEN VACCINE BIOLOGICS CORPORATE EBITDA is −1.08 B TWD, and current EBITDA margin is −277.87%. See more stats in MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements.